November

ERJ November Podcast: high attenuation areas on chest computed tomography in community dwelling adults Eur Respir J 2016; 48: E71
Asthma attacks: should we nail our colours to the mast (cell)? Louise Fleming, Sejal Saglani and Andrew Bush Eur Respir J 2016; 48: 1261-1264
Plasma nitrite/nitrate levels: a new biomarker for pulmonary arterial hypertension? James R. Klinger Eur Respir J 2016; 48: 1265-1267
Prolonged anticoagulation in VTE with direct oral anticoagulants: towards an individual analysis of net clinical benefit? Pierre-Marie Roy Eur Respir J 2016; 48: 1268-1270
Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis? Ivan O. Rosas Eur Respir J 2016; 48: 1271-1273
Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty Vincent Cottin Eur Respir J 2016; 48: 1274-1277
Fighting tuberculosis in the EU/EEA: towards the new European Union standards on tuberculosis care Giovanni Sotgiu, Netta Beer, Stefano Aliberti, Giovanni Battista Migliori and Marieke J. van der Werf Eur Respir J 2016; 48: 1278-1281
Roadmap for tuberculosis elimination in Latin American and Caribbean countries: a strategic alliance Adrian Rendon, Zhenia Fuentes, Carlos A. Torres-Duque, Mirtha del Granado, Jorge Victoria, Raquel Duarte and Giovanni Battista Migliori Eur Respir J 2016; 48: 1282-1287
Lower lung function associates with cessation of menstruation: UK Biobank data André F.S. Amaral, David P. Strachan, Francisco Gómez Real, Peter G.J. Burney and Deborah L. Jarvis Eur Respir J 2016; 48: 1288-1297
The effect of smoking on lung function: a clinical study of adult-onset asthma Minna Tommola, Pinja Ilmarinen, Leena E. Tuomisto, Jussi Haanpää, Terhi Kankaanranta, Onni Niemelä and Hannu Kankaanranta Eur Respir J 2016; 48: 1298-1306
Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study Susan J. Wilson, Jonathan A. Ward, Ana R. Sousa, Julie Corfield, Aruna T. Bansal, Bertrand De Meulder, Diane Lefaudeux,Charles Auffray, Matthew J. Loza, Frederic Baribaud, Neil Fitch, Peter J. Sterk, Kian Fan Chung, David Gibeon, Kai Sun, Yi-ke Guo, Ian Adcock, Ratko Djukanovic, Barbro Dahlen, Pascal Chanez, Dominick Shaw, Norbert Krug, Jens Hohlfeld, Thomas Sandström and Peter H. Howarth on behalf of the U-BIOPRED Study Group Eur Respir J 2016; 48: 1307-1319
Mast cells are associated with exacerbations and eosinophilia in children with severe asthma Guillaume Lezmi, Louise Galmiche-Rolland, Sabine Rioux, Francis Jaubert, Isabelle Tillie-Leblond, Pierre Scheinmann, Philippe Gosset and Jacques de Blic Eur Respir J 2016; 48: 1320-1328
Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis Kohei Hasegawa, Jonathan M. Mansbach, Nadim J. Ajami, Janice A. Espinola, David M. Henke, Joseph F. Petrosino, Pedro A. Piedra, Chad A. Shaw, Ashley F. Sullivan and Carlos A. Camargo Jr on behalf of the MARC-35 Investigators Eur Respir J 2016; 48: 1329-1339
Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation Luigi Taranto-Montemurro, Scott A. Sands, Bradley A. Edwards, Ali Azarbarzin, Melania Marques, Camila de Melo, Danny J. Eckert, David P. White and Andrew Wellman Eur Respir J 2016; 48: 1340-1350
Control theory prediction of resolved Cheyne–Stokes respiration in heart failure Scott A. Sands, Bradley A. Edwards, Kirk Kee, Christopher Stuart-Andrews, Elizabeth M. Skuza, Teanau Roebuck, Anthony Turton, Garun S. Hamilton, Matthew T. Naughton and Philip J. Berger Eur Respir J 2016; 48: 1351-1359
Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism Marisa Peris, David Jiménez, Ana Maestre, Carme Font, Alfonso J. Tafur, Lucia Mazzolai, Belén Xifre, Andris Skride, Francesco Dentali, Manuel Monreal and the RIETE Investigators Eur Respir J 2016; 48: 1360-1368
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Frederikus A. Klok, Volker Hösel, Andreas Clemens, Wilfrid D. Yollo, Clemens Tilke, Sam Schulman, Mareike Lankeit and Stavros V. Konstantinides Eur Respir J 2016; 48: 1369-1376
Right heart thrombi in pulmonary embolism Deisy Barrios, Vladimir Rosa-Salazar, David Jiménez, Raquel Morillo, Alfonso Muriel, Jorge del Toro, Luciano López-Jiménez, Dominique Farge-Bancel, Roger Yusen and Manuel Monreal, for the RIETE investigators Eur Respir J 2016; 48: 1377-1385
Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension Rui Zhang, Xiao-Jian Wang, Hong-Da Zhang, Xiao-Qing Sun, Qin-Hua Zhao, Lan Wang, Jing He, Xin Jiang, Jin-Ming Liu and Zhi-Cheng Jing Eur Respir J 2016; 48: 1386-1395
The economic effects of supporting tuberculosis-affected households in Peru Tom Wingfield, Marco A. Tovar, Doug Huff, Delia Boccia, Rosario Montoya, Eric Ramos, James J. Lewis, Robert H. Gilman and Carlton A. Evans Eur Respir J 2016; 48: 1396-1410
First evaluation of QuantiFERON-TB Gold Plus performance in contact screening Lucia Barcellini, Emanuele Borroni, James Brown, Enrico Brunetti, Daniela Campisi, Paola F. Castellotti, Luigi R. Codecasa, Federica Cugnata, Clelia Di Serio, Maurizio Ferrarese, Delia Goletti, Marc Lipman, Paola M.V. Rancoita, Giulia Russo, Marina Tadolini, Elisa Vanino and Daniela M. Cirillo Eur Respir J 2016; 48: 1411-1419
Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands Connie G.M. Erkens, Erika Slump, Maurits Verhagen, Henrieke Schimmel, Frank Cobelens, Susan van den Hof Eur Respir J 2016; 48: 1420-1428
Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) Vincent Cottin, Elisabeth Bel, Paolo Bottero, Klaus Dalhoff, Marc Humbert, Romain Lazor, Renato A. Sinico, Pasupathy Sivasothy, Michael E. Wechsler, Matthieu Groh, Sylvain Marchand-Adam, Chahéra Khouatra, Benoit Wallaert, Camille Taillé, Philippe Delaval, Jacques Cadranel, Philippe Bonniaud, Grégoire Prévot, Sandrine Hirschi, Anne Gondouin, Bertrand Dunogué, Gérard Chatté, Amandine Briault, David Jayne, Loïc Guillevin, Jean-François Cordier and the Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM“O”P) Eur Respir J 2016; 48: 1429-1441
High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study Anna J. Podolanczuk, Elizabeth C. Oelsner, R. Graham Barr, Eric A. Hoffman, Hilary F. Armstrong, John H.M. Austin, Robert C. Basner, Matthew N. Bartels, Jason D. Christie, Paul L. Enright, Bernadette R. Gochuico, Karen Hinckley Stukovsky, Joel D. Kaufman, P. Hrudaya Nath, John D. Newell Jr, Scott M. Palmer, Dan Rabinowitz, Ganesh Raghu, Jessica L. Sell, Jered Sieren, Sushil K. Sonavane, Russell P. Tracy, Jubal R. Watts, Kayleen Williams, Steven M. Kawut and David J. Lederer Eur Respir J 2016; 48: 1442-1452
Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997–2008 John P. Hutchinson, Tricia M. McKeever, Andrew W. Fogarty, Vidya Navaratnam and Richard B. Hubbard Eur Respir J 2016; 48: 1453-1461
Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases Alberto Ruano-Ravina, María Torres-Durán, Karl T. Kelsey, Isaura Parente-Lamelas, Virginia Leiro-Fernández, Ihab Abdulkader, José Abal-Arca, Carmen Montero-Martínez, Iria Vidal-García, Margarita Amenedo, Olalla Castro-Añón, Antonio Golpe-Gómez, Javier González-Barcala, Cristina Martínez, Rosirys Guzmán-Taveras, Mariano Provencio, María José Mejuto-Martí, Alberto Fernández-Villar and Juan Miguel Barros-Dios Eur Respir J 2016; 48: 1462-1470
Exercise, ageing and the lung Michael A. Roman, Harry B. Rossiter and Richard Casaburi Eur Respir J 2016; 48: 1471-1486
Trends in mortality from respiratory system diseases in Greece during the financial crisis Filippos T. Filippidis, Vasiliki Gerovasili, William D-C. Man and Jennifer K. Quint Eur Respir J 2016; 48: 1487-1489
Acromegaly in sleep apnoea patients: a large observational study in 755 patients Louis-Marie Galerneau, Jean-Louis Pepin, Anne-Laure Borel, Olivier Chabre, Marc Sapene, Bruno Stach, Janie Girey-Rannaud, Nathalie Arnol, Renaud Tamisier and Philippe Caron, on behalf of the scientific council and investigators of the French national sleep apnoea registry (OSFP) Eur Respir J 2016; 48: 1489-1492
Introduction of the 13-valent pneumococcal conjugate vaccine in an isolated pneumococcal vaccine-naïve indigenous population Lilly M. Verhagen, Ismar A. Rivera-Olivero, Meyke Hermsen, María Carolina Sisco, Mailis Maes, Berenice del Nogal, Debby Bogaert, Guy A.M. Berbers, Peter W.M. Hermans, Marien I. de Jonge and Jacobus H. de Waard Eur Respir J 2016; 48: 1492-1496
Multidrug-resistant tuberculosis in children in northwest Russia: an observational cohort study Polina A. Smirnova, Anna Turkova, Elena I. Nikishova, James A. Seddon, Elizabeth Chappell, Olga A. Zolotaya, Oxana M. Mironuk and Andrey O. Maryandyshev Eur Respir J 2016; 48: 1496-1499
Treatment of human disease due to Mycobacterium bovis: a systematic review Zhiyi Lan, Mayara Bastos and Dick Menzies Eur Respir J 2016; 48: 1500-1503
Faster for less: the new “shorter” regimen for multidrug-resistant tuberculosis Giovanni Sotgiu, Simon Tiberi, Lia D’Ambrosio, Rosella Centis, Jan Willem Alffenaar, Jose A. Caminero, Marcos Abdo Arbex, Valentina Alarcon Guizado, Alena Aleksa, Simone Dore, Mina Gaga, Gina Gualano, Heinke Kunst, Marie-Christine Payen, Aurora Jazmín Roby Arias, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Alimuddin Zumla and Giovanni Battista Migliori for the International Carbapenem Study Group Eur Respir J 2016; 48: 1503-1507
Variation in vitamin D deficiency among tuberculosis patients by ethnic group and geographical region of birth: evidence from a diverse south London population Adam Pilarski, Nicole Penn, Sharenja Ratnakumar, Richard D. Barker and Heather J. Milburn Eur Respir J 2016; 48: 1507-1510
Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency Alice Ballerie, Stanislas Nimubona, Catherine Meunier, Francisco Llamas Gutierrez, Benoît Desrues, Philippe Delaval and Stéphane Jouneau Eur Respir J 2016; 48: 1510-1514
Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertension Peter M. Hickey, Alfred A.R. Thompson, Athanasios Charalampopoulos, Charles A. Elliot, Neil Hamilton, David G. Kiely, Allan Lawrie, Ian Sabroe and Robin Condliffe Eur Respir J 2016; 48: 1514-1516
Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity Marianne Riou, Andrei Seferian, Laurent Savale, Marie-Camille Chaumais, Christophe Guignabert, Matthieu Canuet, Pascal Magro, Delphine Rea, Olivier Sitbon, Xavier Jaïs, Marc Humbert and David Montani Eur Respir J 2016; 48: 1517-1519
Opioids in COPD: a cause of death or a marker of illness severity? James Downar, Rebecca Colman, Robert Horton, Paul Hernandez and Graeme Rocker; Nicholas T. Vozoris, Denis E. O’Donnell, Chaim M. Bell, Sudeep S. Gill and Paula A. Rochon Eur Respir J 2016; 48: 1520-1521
Opioids in COPD: a cause of death or a marker of illness severity? Nicholas T. Vozoris, Denis E. O'Donnell, Chaim M. Bell, Sudeep S. Gill, Paula A. Rochon Eur Respir J 2016; 48: 1521-1522
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns Leticia Kawano-Dourado, Fernando Zampieri, Alexandre Biasi Cavalcanti, Lucas Petri Damiani and Ronaldo Adib Kairalla; Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher Eur Respir J 2016; 48: 1523-1524
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler, Toby M. Maher Eur Respir J 2016; 48: 1524-1526
Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine Robert S. Wallis; Marina Tadolini, Rangjung Dolma Lingtsang, Simon Tiberi, Martin Enwerem, Lia D’Ambrosio, Tsetan Dorji Sadutshang, Rosella Centis and Giovanni Battista Migliori Eur Respir J 2016; 48: 1526-1527
Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine Marina Tadolini, Rangjung Dolma Lingtsang, Simon Tiberi, Martin Enwerem, Lia D'Ambrosio, Tsetan Dorji Sadutshang, Rosella Centis, Giovanni Battista Migliori Eur Respir J 2016; 48: 1527-1529
Restricted accessTuberculosis prevention must integrate technological and basic care innovation Heidi Albert, Ruvandhi R. Nathavitharana, Claudia M. Denkinger, Chris Isaacs, Catharina C. Boehme Eur Respir J 2016; 48: 1529-1531
Tuberculosis prevention must integrate technological and basic care innovation Paul H. Mason, Tolu Oni, Maarten M.J.W. van Herpen and Anna K. Coussens; Heidi Albert, Ruvandhi R. Nathavitharana, Claudia M. Denkinger, Chris Isaacs and Catharina C. Boehme Eur Respir J 2016; 48: 1531-1532
AUTHOR CORRECTION “Continuous fat-free mass decline in COPD: fact or fiction?” Erica P.A. Rutten, Martijn A. Spruit, Merry-Lynn N. McDonald, Stephen Rennard, Alvar Agusti, Bartolome Celli, Bruce E. Miller, Courtney Crim, Peter M.A. Calverley, Corrine Hanson, William MacNee, Frits M.E. Franssen, Lowie Vanfleteren and Emiel F.M. Wouters on behalf of the ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points) Investigators. Eur Respir J 2015; 46: 1496–1498. Eur Respir J 2016; 48: 1533